ReviewInternational journal of clinical pharmacy2021
Managing medicines in the time of COVID-19: implications for community-dwelling people with dementia.
Review in International journal of clinical pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 21 citations in OpenAlex.
- Article
- Patterns of psychotropic drug prescriptions and general practice consultations among community-dwelling older people with dementia during the first two years of the COVID-19 pandemic.BMC geriatrics · 2024Article
- Exploring the role of a facilitator in supporting family carers when embedding the iSupport for Dementia programme in care services: A qualitative study.Journal of clinical nursing · 2023Article
- Community pharmacists' expanding roles in supporting patients before and during COVID-19: An exploratory qualitative study.International journal of clinical pharmacy · 2023Article
- Racial Differences in the Dementia Caregiving Experience During the COVID-19 Pandemic: Findings From the National Health and Aging Trends Study (NHATS).The journals of gerontology. Series B, Psychological sciences and social sciences · 2022Article
- Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.Journal of economic behavior & organization · 2022Article
- Trends in Health Service Use for Canadian Adults With Dementia and Parkinson Disease During the First Wave of the COVID-19 Pandemic.JAMA health forum · 2022Article
- Care for dementia patients and caregivers amid COVID-19 pandemic.Cerebral circulation - cognition and behavior · 2022Review
- Optimising Medication Use along Dementia Progression: Recommendations from a Qualitative Study.Healthcare (Basel, Switzerland) · 2021Article
- Systematic Review on the Mental Health and Treatment Impacts of COVID-19 on Neurocognitive Disorders.Journal of personalized medicine · 2021Review
- Rapid realist review of the role of community pharmacy in the public health response to COVID-19.BMJ open · 2021Review
- The experiences of the community pharmacy team in supporting people with dementia and family carers with medication management during the COVID-19 pandemic.Research in social & administrative pharmacy : RSAP · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 has changed life beyond recognition for millions of individuals, as countries implement social distancing measures to prevent disease transmission. For certain patient groups, such as community-dwelling older people with dementia (PwD), these restrictions may have far-reaching consequences. Medicines management may be adversely affected and deserves careful thought. PwD face unique challenges with medicines management compared to other older people, often relying upon support from family/carers and primary healthcare professionals. This article considers potential issues that PwD may face with each component of medicines management (prescribing, dispensing, administration, adherence, review), and based on previous research, highlights strategies to support PwD and their carers during this time. Primary healthcare professionals must be attentive to medicines-related needs of community-dwelling PwD, particularly those living alone, both during the pandemic and as restrictions are lifted. Carers of PwD continue to have a critical role to play in medicines management, and also require support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.